2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
ASCO® 2024 Insights: "Novel RNA-Nanoparticle Vaccine for the Treatment of Early Melanoma Recurrence Following Adjuvant Anti-PD-1 Antibody Therapy"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Bently Doonan
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Bently Doonan
Login to view comments.
Click here to Login